Food Security Survey Module and was classified into three categories: food security, moderate food insecurity and severe food insecurity. The association between FI, HIV viral load, and CD4 count was assessed using a stabilized inverse probability weighted marginal structural model.
Introduction
Food insecurity (FI), defined as a limited or uncertain ability to acquire acceptable foods in socially acceptable ways, or limited or uncertain availability of nutritionally adequate and safe foods [1] , is a significant social and health problem in Canada, where > 8% of households experienced some level of FI in 2011À2012 [2] . Among people living with HIV, the proportion is even higher. For example, several Canadian studies have consistently found that more than half of HIV-infected participants experienced FI [3] [4] [5] .
Food insecurity is associated with a number of potential health problems, including poorer self-rated health, hypertension and depression, among the general population [6] [7] [8] [9] . Among people living with HIV, FI may have additional HIV-related consequences, such as poor adherence to combined antiretroviral treatment (cART), poor HIV virological control, and poor immune recovery when they have FI [10] [11] [12] [13] . In addition, risky sexual behaviour and injecting drug use (IDU) behaviour are also more likely to occur when people experience FI [14] [15] [16] . While poorly controlled HIV and poor immune recovery compromise individual health status, subsequent increases in community viral load [17] and the presence of risky sexual and injection behaviours [15, 16] will facilitate HIV transmission. Therefore, FI may pose challenges to both individuals and public health when it occurs among people who are living with chronic infectious diseases, such as HIV infection.
As a consequence of similar routes of infection, hepatitis C virus (HCV) infection is common among HIVinfected people [18] , and with the advent of cART, HCVrelated liver disease became the main cause of mortality among HIV/HCV-infected people [19, 20] . However, recent empirical evidence has shown that the prevalence of HCV infection is declining in developed countries as a result of the reduction in new infections [21] [22] [23] . The recent introduction of more effective and tolerable HCV therapies, namely direct-acting antivirals (DAAs), may further contribute to the declining trend of HCV infection in the long term [24] . Nevertheless, the current prevalence of HCV infection among HIV-infected people is up to 15À30% in North America [25, 26] , so HIV/HCV-coinfected people are an important population subgroup. While coinfected people share many important characteristics with those who are HIV monoinfected, some additional characteristics may make this group particularly vulnerable. These include higher rates of IDU, levels of hepatic fibrosis and occurrence of chronic hepatotoxicity related to cART [27] .
Although several prior studies have assessed the association between FI, HIV viral load and CD4 count [10] [11] [12] [13] 28, 29] , we are not aware of work assessing this association exclusively among HIV/HCV-coinfected people. In addition, the majority of published studies on this association were cross-sectional in nature and the temporal relationships between exposure and outcome were unclear. This problem is exacerbated when the association between exposure and outcome is bidirectional, such as the association between FI and HIV-related health outcomes [30] . Furthermore, while cohort studies can better account for temporality, the appropriate use of analytical tools is necessary to estimate meaningful and unbiased associations [31] . For example, in a repeatedly measured cohort study, current HIV viral load and CD4 count are likely time-varying confounders. While adjusting for its confounding effect through conventional regression methods will introduce collider stratification bias [32] , failing to adjust for it will confound subsequent exposureÀoutcome associations.
Marginal structural models allow for the unbiased estimation of effects in the presence of time-varying confounders affected by prior exposure [31, 33, 34] . In this study, we examined the association between FI, HIV viral load and CD4 count among HIV/HCV-coinfected people participating in a Canadian cohort study using marginal structural model.
Methods

Study population
We used data from the Food Security & HIV-HCV SubStudy (FS Sub-study) of the Canadian Co-infection Cohort (CCC) study [35] . The CCC study, initiated in 2003, is a nationwide prospective cohort study that includes 18 treatment sites across Canada and collects data on HIV/ HCV-coinfected people every 6 months [27] . Sociodemographic, socioeconomic, behavioural, clinical and laboratory data are collected at each study visit. The FS Sub-study was a mixed-methods cohort study initiated within the CCC study in 2012 [4, 35] . All CCC participants were invited to enroll in the FS Sub-study and data on FI, depression, health care utilization and medication adherence were collected at the same CCC visit. Both the FS Sub-study and the CCC study were approved by the research ethics boards of the participating institutions [27] ; the secondary use of data in this study was approved by the McGill University Health Centre Research Ethics Board.
Exposure measurement (food insecurity)
FI was measured using the adult scale of the Canadian Community Health Survey's (CCHS) Household Food Security Survey Module (HFSSM) [36] (a 10-item questionnaire); the HFSSM is based on the validated US Food Security Survey Module [37] . While the CCHS questionnaire measures FI over the past 12 months [36] , the FS Sub-study measured FI status over the past 6 months; this was done to synchronize the FS Sub-study data collection procedure with that of the CCC study [27] . In accordance with the CCHS categorization [36] , FI was classified into three categories: food security (zero or one affirmative answer on the HFSSM), moderate food insecurity (two to five affirmative answers) and severe food insecurity (six or more affirmative answers).
Outcome measurement (HIV viral load and CD4 cell count)
Both CD4 count (cells/lL) and HIV viral load (HIV-1 RNA copies/mL) were measured once every 6 months based on the CCC study protocol [27] . As current treatment guidelines recommend initiation of cART regardless of CD4 count [38, 39] , this continuous measure was not classified into categories. Instead, a natural log-transformed CD4 count was used as a continuous outcome variable. However, an HIV viral load < 50 copies/mL is often used as a measure of treatment success [40] . Therefore, HIV viral load was classified as detectable (≥ 50 copies/mL) and undetectable (< 50 copies/mL).
Covariate measurement
Data for age (years), sex (male vs. female), marital status (married or having a common law partner vs. single, widowed or divorced), race (white, aboriginal or other), education level (less than high school, high school or some college), income (≤ 1000, 1001À3000 or > 3000 Canadian $ per month) and IDU in the past 6 months (yes vs. no) were collected biannually through self-reports in questionnaires. Depression status was measured using the short version of the Center for Epidemiologic Studies Depression Scale (CES-D-10) [41] . This is a 10-item questionnaire assessing depressive symptoms in the past week. Each item has a four-point continuum from 0 to 3 and total score ranges from 0 to 30. Depression status was classified as absence of depressive symptoms if the total score was ≤ 10 and presence of depressive symptoms if it was > 10. Adherence was measured using the AIDS Clinical Trials Group (ACTG) Adherence Questionnaire [42] , but we used the question "If you have missed doses during past 4 days, how many days have you missed all doses?" to define adherence level following prior literature [43] . Adherence was classified as perfect if there were zero reported missing days or imperfect otherwise.
Multiple imputation
Although the maximum number of missing values of any given variable was low (Table 1) , this problem is compounded as the number of variables included in the analysis and the number of follow-up visits increases. Therefore, multiple imputation by chained equations [44] was used to impute missing values using 20 imputations with 100 iterations. Continuous variables were imputed by predictive mean matching; binomial variables were imputed using logit link; unordered categorical variables such as race were imputed with multinomial logistic link (mlogit link); ordered categorical variables such as educational level were imputed with ordinal logistic link (ologit link) [45] .
Statistical analysis
To account for potential time-varying confounders affected by prior exposure, stabilized inverse probability weights (SWs) were calculated by arranging the data set in long format (one person-visit per row) [31, 33, 46] . Sex, education, marital status, and IDU were used as time invariant confounders, while depression, HIV viral load APRI, aspartate aminotransferase to platelet ratio index; CAD, Canadian dollars; cART, combination antiretroviral therapy; IDU, injecting drug use. Values are median (interquartile range) or n (%). *Number (%) of patients achieving undetectable hepatitis C virus (HCV) viral load 3 months after discontinuing HCV treatment.
and restricted cubic spline for natural log-transformed CD4 count measured at the prior visit were used as timevarying confounders (see Appendix S1 for an assumed directed acyclic graph and Appendix S2 for the stabilized weight calculation). SW weighted outcome models, which are equivalent to marginal structural models, were fitted with the robust sandwich variance estimator to account for within-subject clustering induced by repeated measurement and weighting. Specifically, a weighted linear regression model was used for the association between FI and log-transformed CD4 count, and a Poisson regression model with log link was used for the association between FI and detectable HIV viral load [47, 48] . The final point estimates and variances were combined across 20 imputed data sets using Rubin's rule [49] . In addition, a series of sensitivity analyses were conducted to assess the robustness of the association and potential collider stratification bias introduced by conditioning on time-varying confounders [32, 50] . These were as follows.
(1) A treatment indicator variable (on cART or not on cART) was included in the weight model as a baseline confounder in addition to existing variables used for the SW calculation. We assumed that HIV viral load and CD4 count are downstream variables relative to treatment indicator variable, and inclusion of HIV viral load and CD4 count as time-varying confounders should account for the confounding effect of the treatment indicator variable. (2) The study sample was restricted to those who were on treatment (125 person-visits were excluded from a total of 1973 person-visits), and cART adherence measured at the prior visit was included in the weight model as a time-varying confounder in addition to HIV viral load and CD4 count with the same assumption as in sensitivity analysis 1. (3) With the same study sample as above, we used cART adherence measured at the prior visit as a time-varying confounder and excluded both HIV viral load and CD4 count from the weight model. In this analysis, we aimed to test if self-reported cART adherence is a good representation of actual adherence. We hypothesized that self-reported cART adherence should be able to capture all information included in HIV viral load and CD4 count if it represents the patient's actual adherence level. The result from this sensitivity analysis should be similar to that from the main analysis if the above hypothesis is correct. (4) Time-varying confounders along with baseline confounders were accounted for through standard regression adjustment to assess the potential impact of inappropriate adjustment of time-varying confounders on the exposureÀoutcome association.
In order to assess if a longer duration of FI has a more severe impact on HIV viral load and CD4 count, any FI that occurred at two or more consecutive study visits was defined as exposed. In this dichotomous exposure setting, the same potential confounders as in the main analysis were used. In addition, the exposure was lagged by one visit to assure that the outcome corresponds to the newly defined exposure.
Results
HIV/HCV-coinfected patients were enrolled in this study from 15 November 2012 to 15 October 2015 and followed every 6 months for a maximum of five study visits. The number of patients completing each study visit were 725, 608, 420, 203 and 17, respectively, contributing 1973 person-visits in total. At the baseline visit, 57% of patients experienced moderate or severe food insecurity and this percentage remained at around 50% throughout followup. The proportions of patients with undetectable HIV viral load were 75%, 79%, 82%, 87% and 88% at each study visit, and the median CD4 counts were 460, 480, 499, 532 and 530, respectively. The proportions of patients receiving HCV treatment at each study visit were 2.2%, 4.6%, 2.9%, 5.4% and 11.8%, respectively, and the proportions achieving undetectable HCV viral load 3 months after discontinuation of HCV treatment ranged from 44 to 60% throughout the study visits. The median aspartate aminotransferase to platelet ratio index (APRI) varied from 0.59 [interquartile range (IQR): 0.37, 1.17] to 0.46 (IQR: 0.32, 1.07) across visits. Important sociodemographic, socioeconomic and clinical characteristics of study participants at baseline are presented in Table 1 .
The main study results are presented in Table 2 . Compared with people with no FI, people experiencing severe FI had 1.47 [95% confidence interval (CI): 1.14, 1.88] times the risk of having a detectable HIV viral load, and they had a 0.91-fold (95% CI: 0.84, 0.98) increase in CD4 cell count on average (in other words, they had 9% fewer CD4 cells than people who were food secure). Moderate FI, however, did not have a statistically significant impact on either HIV viral load or CD4 count, although the point estimates for these associations were consistent with those found for severe FI. The SW distribution used for this analysis is displayed in Appendix S3, and was stable throughout follow-up.
In the sensitivity analyses: (1) inclusion of a treatment indicator variable as an additional baseline confounder; (2) inclusion of cART adherence measured at a prior visit as a time-varying confounder; and (3) inclusion of cART adherence measured at a prior visit as a time-varying confounder by excluding both HIV viral load and CD4 count measured at the prior visit from the weight model did not change the main results meaningfully (sensitivity analyses 1, 2 and 3 in Table 3 ). In the last model (sensitivity analysis 4 in Table 3 ), where all baseline and timevarying confounders were adjusted through regression conditioning, only the association between severe food insecurity and detectable HIV viral load remained significant, and the point estimate decreased by 28% [calculated as (log(1.47) À log(1.32))/log(1.47)]. Table 4 presents results from analyses that used a slightly different exposure classification. When the exposure was defined as having FI (any level) at two or more consecutive visits, the associations both for HIV viral load and CD4 count were equivalent to the association for severe FI presented in Table 2 .
Discussion
We assessed the association between FI and both HIV viral load and CD4 count among HIV/HCV-coinfected people in Canada using prospectively collected data from the FS Sub-Study of the CCC study [27, 35] . The results indicated that severe FI was associated with increased risk of having detectable HIV viral load and lower CD4 count among HIV/HCV-coinfected individuals. Our findings are consistent with the results of recent meta-analyses that summarized associations between FI and both HIV viral load and CD4 count among HIV-infected people with an unknown proportion of HCV coinfection [51, 52] , and provide evidence that FI is a risk factor for poor treatment outcomes among people coinfected with HIV/HCV. While the potential pathways through which FI affects HIV viral suppression and immune reconstitution remain unknown, it is very likely that poor medication adherence mediates the effect. Indeed, prior studies among HIV-infected people have suggested this pathway [10, 12] . Suboptimal adherence leads to HIV drug resistance [53] , jeopardizes immune reconstitution and accelerates progression to AIDS. In addition, it may substantially change drug resistance profiles in the community if patients are already on second-line and third-line treatment regimens.
Since the introduction of cART, HCV-related liver disease has emerged as a leading non-HIV-related cause of death among HIV/HCV-coinfected people [19, 20, 54] . A French study documented a steady increase in the SD, standard deviation. *Mean and standard deviation were calculated individually for each imputed data set and then combined using Rubin's rule [49] . †
The minimum and maximum values were based on the entire imputed data set. proportion of liver-related deaths from 1995 to 2001 [55] . Recently, however, there have been major advancements in the treatment of HCV infection with the introduction of DAAs [24, 56] . This may significantly improve the rate of sustained virological response (SVR) and associated HCV-related morbidity and mortality. Although DAAs have superior effectiveness in HCV treatment, adherence is required to achieve SVR. Therefore, FIassociated suboptimal adherence may compromise their beneficial effects. In other words, HIV/HCV-coinfected people may not benefit from this new class of treatment if they experience FI. A recent study in sub-Saharan Africa showed that food supplementation can increase treatment adherence [57] . Given the high proportion of FI among this population, food supplementation, therefore, may be a viable option to improve treatment adherence and subsequent health outcomes. In the sensitivity analyses, when a baseline treatment indicator and cART adherence at prior visit were added separately to weight models, the original association obtained in the main analysis were not altered (sensitivity analyses 1 and 2 in Table 3 ). This is an indication that the assumption regarding the causal structure in Appendix S1 is upheld. In other words, once the confounding effects of HIV viral load and CD4 count are taken into account, both treatment indicator and cART adherence become irrelevant. In sensitivity analysis 3, inclusion of cART adherence as a time-varying confounder and exclusion of both HIV viral load and CD4 count from the weight model produced similar results to the main model. This suggests that self-reported adherence may represent the actual adherence level and capture the information included in HIV viral load and CD4 count. In the last model, all associations shifted towards the null and the one that remained significant was also substantially attenuated. This may be attributable to collider stratification bias introduced by conditioning on potential time-varying confounders [32] . Our intention for the last sensitivity analysis was to show how the inappropriate use of analytical methods may bias the results.
When any FI that occurred at two or more consecutive study visits was defined as the exposure, the association between FI, HIV viral load, and CD4 count significantly strengthened and became equivalent to that seen with severe FI. This result suggests that sustained FI of any level that lasted for two or more consecutive visits had a similar effect on HIV viral load and CD4 count to severe food insecurity that occurred only once. In order to clarify if this doseÀresponse relationship was mainly driven by severe FI after collapsing moderate and severe FI into one category, we empirically examined the proportion of FI level at each study visit and found that the proportion ranged from 20% to 35% for moderate FI and from 25% to 35% for severe FI. Therefore, the result of this analysis is unlikely to be driven only by severe FI.
This study has some unique features and strengths. First, this is a cohort study with a clear temporal sequence between variables measured at multiple visits. Secondly, as it is possible to have time-varying confounders in a repeatedly measured cohort study, an epidemiological method specifically designed to tackle this problem was applied to obtain association measures. Thirdly, the study population is comprised exclusively of HIV/HCV-coinfected subjects. HIV/HCV-coinfected people tend to have significantly higher mortality compared with HIV-monoinfected individuals [58] . As uncontrolled HIV infection is probably associated with this excess mortality [54] , identifying potential factors associated with poor HIV viral control among HIV/HCV-coinfected people may provide some insights for health professionals. However, there are also several limitations. For example, we cannot claim a causal relationship between FI, HIV viral suppression and CD4 count even though we applied causal inference methodology. First, in order to have a causal association, an unverifiable assumption such as no unmeasured confounder needs to be held [31] . Although we believe that the most important confounders were included in the analysis, given the complex psychosocial characteristics involved in FI, there may be potential confounders that were not included in the model. Secondly, FI may not correspond to a well-defined intervention. There are different reasons for a patient to experience FI [3, 4] and each reason may have different implications for having detectable HIV viral load and lower CD4 count. In other words, the necessary condition for a causal inference, the counterfactual consistency assumption, may not hold for this exposure [59] .
In summary, we found that severe FI is associated with detectable HIV viral load and lower CD4 count among HIV/HCV-coinfected people. Additionally, there is a clear doseÀresponse relationship in terms of severity and duration of FI. Addressing FI among people coinfected with HIV/HCV may improve HIV-related health outcomes.
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